Arvinas, Inc. (ARVN)
10.51
+0.61
(+6.16%)
USD |
NASDAQ |
May 01, 16:00
10.53
+0.02
(+0.19%)
After-Hours: 20:00
Arvinas EPS Diluted (Quarterly) : -1.038 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| EyePoint, Inc. | -0.8143 |
| Apellis Pharmaceuticals, Inc. | -0.4654 |
| Elanco Animal Health, Inc. | -0.5554 |
| Gossamer Bio, Inc. | -0.2085 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.40M |
| Revenue (Quarterly) | 9.50M |
| Total Expenses (Quarterly) | 76.90M |
| Enterprise Value | -4.070M |
| Gross Profit Margin (Quarterly) | 87.37% |
| Profit Margin (Quarterly) | -709.5% |
| Earnings Yield | -11.57% |
| Normalized Earnings Yield | -11.20 |